Siga supplies tpoxx® (tecovirimat) as compassionate treatment for monkeypox case in the united kingdom

New york, june 30, 2021 (globe newswire) -- siga technologies, inc. (siga) (nasdaq: siga), a commercial-stage pharmaceutical company focused on the health security market, today announced that it provided tpoxx® (tecovirimat) to liverpool university hospitals nhs foundation trust, in the united kingdom (uk). tpoxx, which is approved in the united states for the treatment of smallpox, was delivered to liverpool for compassionate treatment for a patient confirmed to be infected with monkeypox.
SIGA Ratings Summary
SIGA Quant Ranking